Literature DB >> 23293160

Evaluation of diagnostic assays for the serological detection of Actinobacillus pleuropneumoniae on samples of known or unknown exposure.

Tanja Opriessnig1, Michelle Hemann, John K Johnson, Sheila Heinen, Luis G Giménez-Lirola, Kevin C O'Neill, Hai Hoang, Kyoung-Jin Yoon, Marcelo Gottschalk, Patrick G Halbur.   

Abstract

Accurate diagnosis of exposure to Actinobacillus pleuropneumoniae is important for maintaining negative farms. In the present study, the ability of a dual-plate complement fixation (CF) assay and 3 commercially available enzyme-linked immunosorbent assays (ELISAs; quad-plate ELISA-1, single-plate ELISA-2, and single-plate ELISA-3) in detecting serological evidence of A. pleuropneumoniae exposure was compared using serum samples of experimentally infected or vaccinated pigs, or field samples from the United States. Forty-two pigs were divided into groups of 2 pigs and were inoculated with 1 of 15 A. pleuropneumoniae strains representing all known serovars of A. pleuropneumoniae, or with Actinobacillus suis, or were vaccinated with a bacterin containing A. pleuropneumoniae serovar 1, 3, 5, or 7. Serum samples collected at the day of inoculation or vaccination and 7, 14, 21, and 28 days later were used to compare the assays. On samples from experimentally infected pigs, the dual-plate CF assay, quad-plate ELISA-1, single-plate ELISA-2, and single-plate ELISA-3 had sensitivities of 0.46, 0.74, 0.13, and 0.13 and specificities of 0.90, 1.0, 1.0, and 1.0, respectively. Vaccinated pigs were identified only by the dual-plate CF assay and the quad-plate ELISA-1. In addition, 90 serum samples with unknown A. pleuropneumoniae exposure collected under field conditions were tested with all assays. The agreement of the 4 assays on field samples was slight to fair. While several assays are available for demonstration of A. pleuropneumoniae exposure, differences in assay targets complicate test choices. Decisions on which assay or combination of assays to use depend on the specific reasons for running the assays.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23293160     DOI: 10.1177/1040638712469607

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  5 in total

1.  Exposure of feral swine (Sus scrofa) in the United States to selected pathogens.

Authors:  John A Baroch; Carl A Gagnon; Sonia Lacouture; Marcelo Gottschalk
Journal:  Can J Vet Res       Date:  2015-01       Impact factor: 1.310

2.  Simultaneous detection of antibodies against Apx toxins ApxI, ApxII, ApxIII, and ApxIV in pigs with known and unknown Actinobacillus pleuropneumoniae exposure using a multiplexing liquid array platform.

Authors:  Luis G Giménez-Lirola; Yong-Hou Jiang; Dong Sun; Hai Hoang; Kyoung-Jin Yoon; Patrick G Halbur; Tanja Opriessnig
Journal:  Clin Vaccine Immunol       Date:  2013-11-13

3.  Detection of Actinobacillus Pleuropneumoniae ApxIV Toxin Antibody in Serum and Oral Fluid Specimens from Pigs Inoculated Under Experimental Conditions.

Authors:  Wendy González; Luis G Giménez-Lirola; Ashley Holmes; Sergio Lizano; Christa Goodell; Korakrit Poonsuk; Panchan Sitthicharoenchai; Yaxuan Sun; Jeffrey Zimmerman
Journal:  J Vet Res       Date:  2017-12-06       Impact factor: 1.744

4.  Comparison of four lung scoring systems for the assessment of the pathological outcomes derived from Actinobacillus pleuropneumoniae experimental infections.

Authors:  Marina Sibila; Virginia Aragón; Lorenzo Fraile; Joaquim Segalés
Journal:  BMC Vet Res       Date:  2014-07-19       Impact factor: 2.741

5.  Application of an enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serovar 15 in pig sera.

Authors:  Kaho Teshima; Jina Lee; Ho To; Takashi Kamada; Akihiro Tazumi; Haruna Hirano; Minoru Maruyama; Torata Ogawa; Shinya Nagai; Conny Turni; Nobuyuki Tsutsumi
Journal:  J Vet Med Sci       Date:  2017-10-24       Impact factor: 1.267

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.